StockWatch
·
Pharmaceuticals
Corporate Governance3 Nov 2026, 08:10 pm

Dipna Pharmachem Reconstitutes Board Committees

AI Summary

Dipna Pharmachem Ltd announced the reconstitution of its Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee following a Board of Directors meeting held on November 3, 2026. The company also appointed Mr. Hiteshkumar Shankarlal Parmar and Mr. Swetal Nalinbhai Shah as Additional Non-Executive and Independent Directors, effective from the same date. Both new directors bring substantial business experience and commercial knowledge to their roles.

Key Highlights

  • Two new Independent Directors appointed to the board.
  • Audit Committee reconstituted with new members.
  • Nomination and Remuneration Committee reconstituted.
  • Stakeholders Relationship Committee also reconstituted.
  • Appointments effective November 3, 2026.